Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Mike who wrote (1762)	8/10/2003 9:16:21 PM
From: Harold Engstrom	Read Replies (2) \| Respond to of 3044

Mike, you spammed up SI a few months ago about MDCO being the next big thing and was rude as hell to anyone who didn't want to drink your kool-aid. By June you said you would have your "bing" (you said, "as in bada-bing") but no bing is to be had. Sure, revenues do look like they will be $75MM+, but $100MM looks like a dream for 2003. And the company does not spell out in there release what percentage of revenues is Angiomax - so $100MM for Angiomax may be even more of an unlikely wish than is immediately apparent. There is still the game to be played so while Angiomax may do OK, there is no guarantee that it will do well enough for MDCO to make any porfit or enough profit to justify its current price.